PLX Operating Cash Flow (Statement)
Protalix Biotherapeutics Inc · Operating Cash Flow (Statement)
PLX Operating Cash Flow (Statement)
Latest reported$9.92Mperiod ending
PLX Cash from Operations (-$40.57K → $9.92M)
Annual operating cash flow (statement)
High-resolution chart · PNG
PLX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -11,993,000 | |
| 8,674,000 | |
| -1,318,000 | |
| -25,000,000 | |
| -10,285,000 | |
| -26,106,000 | |
| -19,358,000 | |
| -7,742,000 | |
| -9,994,000 | |
| -32,098,000 | |
| -24,284,000 | |
| -29,281,000 | |
| -30,653,000 | |
| 635,000 | |
| -23,570,000 | |
| -38,464,000 | |
| 44,452,000 | |
| -16,015,000 | |
| -10,449,000 | |
| -5,091,000 | |
| -72,475 | |
| -168,125 | |
| -136,682 | |
| -146,586 | |
| -789,428 | |
| -53,108 | |
| -1,408,137 | |
| -909,523 | |
| -247,920 | |
| -40,571 |